FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.7.22-SNAPSHOT  |  FHIR Version n/a  User: [n/a]

778532005: Product containing only blinatumomab in parenteral dose form (medicinal product form)

Status: current, Sufficiently defined by necessary conditions definition status (core metadata concept). Date: 31-Jan 2019. Module: SNOMED CT core

Descriptions:

Id Description Lang Type Status Case? Module
3738641011 Product containing only blinatumomab in parenteral dose form (medicinal product form) en Fully specified name Active Entire term case insensitive (core metadata concept) SNOMED CT core
3738642016 Blinatumomab only product in parenteral dose form en Synonym (core metadata concept) Active Entire term case insensitive (core metadata concept) SNOMED CT core
5549981000241112 produit contenant seulement du blinatumomab sous forme parentérale fr Synonym (core metadata concept) Active Entire term case insensitive (core metadata concept) SNOMED CT Switzerland NRC maintained Module

1 descendants. Search Descendants:

Expanded Value Set

Outbound Relationships Type Target Active Characteristic Refinability Group Values
Product containing only blinatumomab in parenteral dose form (medicinal product form) Is a Product containing blinatumomab in parenteral dose form (medicinal product form) true Inferred relationship Some
Product containing only blinatumomab in parenteral dose form (medicinal product form) Count of base of active ingredient un false Inferred relationship Some
Product containing only blinatumomab in parenteral dose form (medicinal product form) Has manufactured dose form Parenteral dose form (dose form) true Inferred relationship Some
Product containing only blinatumomab in parenteral dose form (medicinal product form) Is a Product containing only blinatumomab (medicinal product) true Inferred relationship Some
Product containing only blinatumomab in parenteral dose form (medicinal product form) The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. Blinatumomab (substance) true Inferred relationship Some 1
Product containing only blinatumomab in parenteral dose form (medicinal product form) Plays role Antineoplastic therapeutic role false Inferred relationship Some
Inbound Relationships Type Active Source Characteristic Refinability Group
Blinatumomab 38.5 microgram powder for solution for infusion vial Is a True Product containing only blinatumomab in parenteral dose form (medicinal product form) Inferred relationship Some

This concept is not in any reference sets

Back to Start